Biblio

Lestienne M, Vanniere B, Curt T, Jouffroy-Bapicot I, Hely C.  2022.  Climate-driven Mediterranean fire hazard assessments for 2020-2100 on the light of past millennial variability. CLIMATIC CHANGE. 170:14.

Bougeault C, Pellenard P, Deconinck J-F, Hesselbo SP, Dommergues J-L, Bruneau L, Cocquerez T, Laffont R, Huret E, Thibault N.  2017.  Climatic and palaeoceanographic changes during the Pliensbachian (Early Jurassic) inferred from clay mineralogy and stable isotope (C-O) geochemistry (NW Europe). GLOBAL AND PLANETARY CHANGE. 149:139-152.

Deconinck J-F, Hesselbo SP, Pellenard P.  2019.  Climatic and sea-level control of Jurassic (Pliensbachian) clay mineral sedimentation in the Cardigan Bay Basin, Llanbedr (Mochras Farm) borehole, Wales. SEDIMENTOLOGY. 66:2769-2783.

Camberlin P, Boyard-Micheau J, Philippon N, Baron C, Leclerc C, Mwongera C.  2014.  Climatic gradients along the windward slopes of Mount Kenya and their implication for crop risks. Part 1: climate variability. INTERNATIONAL JOURNAL OF CLIMATOLOGY. 34:2136-2152.

Philippon N, Baron C, Boyard-Micheau J, Adde A, Leclerc C, Mwongera C, Camberlin P.  2016.  Climatic gradients along the windward slopes of Mount Kenya and their implication for crop risks. Part 2: crop sensitivity. INTERNATIONAL JOURNAL OF CLIMATOLOGY. 36:917-932.

Protin M, Schimmelpfennig I, Mugnier J-L, Ravanel L, Le Roy M, Deline P, Favier V, Buoncristiani J-F, Team ASTER.  2019.  Climatic reconstruction for the Younger Dryas/Early Holocene transition and the Little Ice Age based on paleo-extents of Argentiere glacier (French Alps). QUATERNARY SCIENCE REVIEWS. 221:105863.

Baltzer A, Walter-Simonnet A-V, Mokeddem Z, Tessier B, Goubert E, Cassen S, Diffo A.  2014.  Climatically-driven impacts on sedimentation processes in the Bay of Quiberon (south Brittany, France) over the last 10,000 years. HOLOCENE. 24:679-688.

Didi R., Marin A., Girod J.-C, Nicolleau L., Maltaverne D..  2014.  Clinic of forensic pathology of sleep. EUROPEAN PSYCHIATRY. 29:574-575.

Pistilli B, Wildiers H, Hamilton EPaige, Ferreira AAlexandra, Dalenc F, Vidal M, Gavila J, Goncalves A, Murias C, Mouret-Reynier M-A et al..  2020.  Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i).. JOURNAL OF CLINICAL ONCOLOGY. 38

Pistilli B, Wildiers H, Hamilton EPaige, Ferreira AAlexandra, Dalenc F, Vidal M, Gavila J, Goncalves A, Murias C, Mouret-Reynier M-A et al..  2020.  Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i).. JOURNAL OF CLINICAL ONCOLOGY. 38

Melero I., E. Alvarez C, Mau-Sorensen M., Lassen U.N, Lolkema M.P, Robbrecht D.G, Gomez-Roca C.A, Martin-Liberal J., Tabernero J., Ros W. et al..  2018.  Clinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v). ANNALS OF ONCOLOGY. 29

Melero I., E. Alvarez C, Mau-Sorensen M., Lassen U.N, Lolkema M.P, Robbrecht D.G, Gomez-Roca C.A, Martin-Liberal J., Tabernero J., Ros W. et al..  2018.  Clinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v). ANNALS OF ONCOLOGY. 29

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Beneteau C et al..  2019.  Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients. HAEMATOLOGICA. 104:1554-1564.

Chague F., Porot G., Gudjoncink A., Robert R., Beer J.-C, Maza M., Cottin Y., Zeller M..  2018.  Clinical and coronary angiographic characteristics of acute myocardial infarction occurring during sport practice: contemporary data from the RICO survey. EUROPEAN HEART JOURNAL. 39:61-62.

Chague F., Porot G., Gudjoncink A., Robert R., Beer J.-C, Maza M., Cottin Y., Zeller M..  2018.  Clinical and coronary angiographic characteristics of acute myocardial infarction occurring during sport practice: contemporary data from the RICO survey. EUROPEAN HEART JOURNAL. 39:61-62.

Thibouw D, Truc G, Bertaut A, Chevalier C, Aubignac L, Mirjolet C.  2018.  Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy. JOURNAL OF NEURO-ONCOLOGY. 137:429-438.

Vadot L., Boulin M., Guiu B., Aho L.S, Vourc'h M., Musat A., Hillon P., Lepage C., Guignard M.-H, Fagnoni P..  2015.  Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 40:83-90.

de Gregori J, Pistre P, Boutet M, Porcher L, Devaux M, Pernot C, Chretien M, Rossi C, Manfredi S, Dalac S et al..  2020.  Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 26:1078155220915763.

Depner M, Fuchs O, Genuneit J, Karvonen AM, Hyvarinen A, Kaulek V, Roduit C, Weber J, Schaub B, Lauener R et al..  2014.  Clinical and Epidemiologic Phenotypes of Childhood Asthma. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 189:129-138.

Degano B, Soumagne T.  2014.  Clinical and functional assessment in COPD: From case finding to follow-up. PRESSE MEDICALE. 43:1344-1352.

Craddock KE, Okur V, Wilson A, Gerkes EH, Ramsey K, Heeley JM, Juusola J, Vitobello A, Dupeyron M-NBonnet, Faivre L et al..  2019.  Clinical and genetic characterization of individuals with predicted deleterious PHIP variants. COLD SPRING HARBOR MOLECULAR CASE STUDIES. 5:a004200.

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M et al..  2020.  Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome (vol 43, pg 253, 2019). EBIOMEDICINE. 57:102875.

Scholl S, Popovic M, de la Rochefordiere A, Girard E, Dureau S, Mandic A, Koprivsek K, Samet N, Craina M, Margan M et al..  2019.  Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome. EBIOMEDICINE. 43:253-260.

Samimi M., Durieux-Verde M., Caille A., Mazereeuw-Hautier J., Boccara O., Martin L., Chiaverini C., Eschard C., Beneton N., Vabres P. et al..  2018.  Clinical and haemodynamic risk factors associated with discrepancies in lower limb length with capillary malformations: data from the national paediatric French cohort CONAPE. BRITISH JOURNAL OF DERMATOLOGY. 178:520-526.

Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Michel C, Jegou J, Grange F et al..  2014.  Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment A Multicenter, Prospective Study. JAMA DERMATOLOGY. 150:25-33.